TLR4型
毒性
糖脂
糖尿病
MAPK/ERK通路
药理学
骨质疏松症
体外
医学
内科学
内分泌学
生物
受体
生物化学
免疫学
磷酸化
作者
Bo Liang,Xiaodong Shen,Chao Lan,Youfen Lin,Chuanchuan Li,Shuai Zhong,Sunjie Yan
标识
DOI:10.1016/j.intimp.2021.107792
摘要
Diabetes can cause bone metabolism disorders and osteoporosis. The occurrence of both diabetes mellitus and osteoporosis increases the disability and mortality of elderly individuals due to pathological fracture. Abnormal metabolism of nutrientsis considered to be one of the important mechanisms of diabetes mellitus-induced osteoporosis. This study preliminarily explored the roles of TLR4 (Toll-like receptor 4) and S100B in osteogenic dysfunction induced by glycolipid toxicity. In this study, a diabetic rat model and TLR4-knockdown diabetic rat model were used in vivo. MC3T3-E1 cells in a high glucose and palmitic acid environment were used as glycolipid toxicity cell models in vitro. We investigated the effects of TLR4 and S100B on osteogenesis by overexpression or inhibition of TLR4 and S100B in vitro. We found that when TLR4 or S100B was inhibited, ALP and OCN were significantly up-regulated and p-ERK was significantly down regulated in the glycolipid model. These results suggest that TLR4/S100B may play a role in reducing glycolipid toxicity by regulating ERK phosphorylation.
科研通智能强力驱动
Strongly Powered by AbleSci AI